📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: GeminX Pharmaceuticals

1.1 - Company Overview

GeminX Pharmaceuticals Logo

GeminX Pharmaceuticals

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel, targeted cancer therapeutics, dedicated to the discovery, development and commercialization of treatments based on research on the Bcl-2 cell death regulation pathway, including the discovery of GX15-070 (obatoclax), a novel small molecule.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to GeminX Pharmaceuticals

Kuur Therapeutics Logo

Kuur Therapeutics

HQ: United Kingdom Website
  • Description: Provider of off-the-shelf engineered CAR-NKT cell therapies, combining the natural biology of natural killer T cells with innovative CAR constructs for cancer treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kuur Therapeutics company profile →
MediWise Logo

MediWise

HQ: United Kingdom Website
  • Description: Provider of medical research and development, pioneering cutting-edge wireless devices for medical diagnostics and monitoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MediWise company profile →
Viventia Bio Logo

Viventia Bio

HQ: Canada Website
  • Description: Provider of next-generation oncology therapeutics utilizing proprietary Targeted Protein Therapeutic (TPT) technology; a privately held biopharmaceutical company focused on the discovery and development of TPT-based product candidates with potential advantages in treating cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viventia Bio company profile →
iOmx Therapeutics Logo

iOmx Therapeutics

HQ: Germany Website
  • Description: Provider of first-in-class cancer immunotherapies and discovery platforms targeting novel immune checkpoint modulators on tumor cells. Offerings include iOTargTM, a high-throughput genetic screening platform to identify checkpoint molecules; OMX-0407, an oral spectrum-selective SIK inhibitor in first-in-human trials; and IOMX-0675, a dual LILRB1/LILRB2 antibody to re-activate innate and adaptive immunity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full iOmx Therapeutics company profile →
Elevation Oncology Logo

Elevation Oncology

HQ: United States Website
  • Description: Provider of precision medicines as a clinical-stage biopharmaceutical company, developing EO-3021, an antibody-drug conjugate targeting Claudin 18.2 for advanced/metastatic solid tumors, particularly gastric and gastroesophageal junction adenocarcinoma, and Seribantumab, an anti-HER3 monoclonal antibody for NRG1 fusion-positive tumors; conducts clinical trials and offers compassionate use.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elevation Oncology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for GeminX Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to GeminX Pharmaceuticals

2.2 - Growth funds investing in similar companies to GeminX Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for GeminX Pharmaceuticals

4.2 - Public trading comparable groups for GeminX Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to GeminX Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About GeminX Pharmaceuticals

What does GeminX Pharmaceuticals do?

GeminX Pharmaceuticals is a provider of novel, targeted cancer therapeutics, dedicated to the discovery, development and commercialization of treatments based on research on the Bcl-2 cell death regulation pathway, including the discovery of GX15-070 (obatoclax), a novel small molecule.

Who are GeminX Pharmaceuticals's competitors?

GeminX Pharmaceuticals's competitors and similar companies include Kuur Therapeutics, MediWise, Viventia Bio, iOmx Therapeutics, and Elevation Oncology.

Where is GeminX Pharmaceuticals headquartered?

GeminX Pharmaceuticals is headquartered in Canada.

How many employees does GeminX Pharmaceuticals have?

GeminX Pharmaceuticals has 1,000 employees 🔒.

When was GeminX Pharmaceuticals founded?

GeminX Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is GeminX Pharmaceuticals in?

GeminX Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for GeminX Pharmaceuticals

Who are the top strategic acquirers in GeminX Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in GeminX Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for GeminX Pharmaceuticals?

Top strategic M&A buyers groups and sectors for GeminX Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in GeminX Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in GeminX Pharmaceuticals's sector and industry vertical?

Top PE firms investing in GeminX Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in GeminX Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in GeminX Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in GeminX Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to GeminX Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in GeminX Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for GeminX Pharmaceuticals?

The key public trading comparables and valuation benchmarks for GeminX Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for GeminX Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for GeminX Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in GeminX Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for GeminX Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in GeminX Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in GeminX Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for GeminX Pharmaceuticals